Edges in Network
| Network | GSE25065_top8000 - GSE25065 - SiGN-BN NNSR |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | SPARCL1 |
| Upstream (Parents) |
|---|
| (<<) SPARC → SPARCL1 |
| (<<) DCN → SPARCL1 |
| Downstream (Children) |
|---|
| SPARCL1 → JAM2 (>>) |
| SPARCL1 → CORO2B (>>) |
| SPARCL1 → MEOX2 (>>) |
| SPARCL1 → NR2F1 (>>) |
| SPARCL1 → CAV1 (>>) |
| SPARCL1 → DARC (>>) |
| SPARCL1 → CDH5 (>>) |
| SPARCL1 → ADIPOQ (>>) |
| SPARCL1 → EMCN (>>) |
| SPARCL1 → LHFP (>>) |
| SPARCL1 → IL33 (>>) |
| SPARCL1 → IGF1 (>>) |
| SPARCL1 → VWF (>>) |
| SPARCL1 → CCL15///CCL14 (>>) |
| SPARCL1 → COL14A1 (>>) |
| SPARCL1 → C7 (>>) |
| SPARCL1 → PTN (>>) |
| SPARCL1 → ABCA8 (>>) |
| SPARCL1 → DST (>>) |
| SPARCL1 → LDB2 (>>) |
| SPARCL1 → AOX1 (>>) |
| SPARCL1 → L2HGDH (>>) |
| SPARCL1 → SOX17 (>>) |
| SPARCL1 → MATN2 (>>) |
| SPARCL1 → F13A1 (>>) |
| SPARCL1 → F2R (>>) |
| SPARCL1 → HAS1 (>>) |
| SPARCL1 → GEM (>>) |
| SPARCL1 → INS-IGF2///IGF2 (>>) |
| SPARCL1 → CD93 (>>) |
| SPARCL1 → PDLIM1 (>>) |
| SPARCL1 → PPAP2A (>>) |
| SPARCL1 → SRPX (>>) |
| SPARCL1 → FXYD1 (>>) |
| SPARCL1 → COL17A1 (>>) |
| SPARCL1 → SLIT2 (>>) |
| SPARCL1 → CRISPLD2 (>>) |
| SPARCL1 → STEAP1 (>>) |
| SPARCL1 → TGFBR3 (>>) |
| SPARCL1 → VCL (>>) |
| SPARCL1 → TSPAN7 (>>) |
| SPARCL1 → AQP1 (>>) |
